A narrative review on LL-37-based oral antimicrobial therapeutics was published on September 20, 2026. The publication, titled "LL-37-based oral antimicrobial therapeutics: translational challenges and future directions-a narrative review," appeared in the journal Odontology. LL-37 remains classified as an unapproved research compound. The review focuses on translational challenges and future directions related to oral antimicrobial applications of LL-37. As a narrative review, it compiles and discusses existing perspectives on the topic rather than presenting new experimental findings. No specific efficacy or safety outcomes are detailed in the available event data. The article is indexed under PubMed ID 42763374. Readers interested in the broader context of LL-37 research, including its regulatory status and background, can consult the compound overview for additional information.
LL-37 Oral Antimicrobial Review Published in Odontology
Source: https://pubmed.ncbi.nlm.nih.gov/42763374/